The Global Burden of Disease: A Focus on Type II Diabetes
摘要
Type II diabetes (T2D) presents a burgeoning global health crisis, with prevalence escalating from 3.09% to 6.11% between 1990 and 2021 (IHME, GBD results tool. https://vizhub.healthdata.org/gbd-results/ . Accessed 6 Jan 2025, 2021). This chapter synthesizes the multifaceted nature of T2D, highlighting its complex epidemiology, with marked disparities across socioeconomic strata, ethnicities, and age groups. Notably, high body mass index and dietary factors, such as processed meat and sugar-sweetened beverage consumption, are key modifiable risk factors, contributing significantly to the disease burden, particularly in high-income nations. Cardiovascular complications remain the leading cause of mortality among T2D patients. The economic toll is substantial, exceeding USD 966 billion in 2021, with projections indicating a rise to over USD 1 trillion by 2030 (IDF, IDF Diabetes Atlas, 10th edition. International Diabetes Federation (IDF). https://diabetesatlas.org/data/en/ . Accessed 6 Jan 2025, 2021). These findings underscore the imperative for targeted public health interventions, including dietary modifications, early screening, and culturally tailored management strategies, to mitigate the escalating individual, societal, and economic impact of T2D.